Generate Biomedicines
Clinical trials sponsored by Generate Biomedicines, explained in plain language.
-
First human test begins for new lung disease drug
Disease control OngoingThis is the first study in humans to test the safety and side effects of a new drug called GB-0895. It involves 156 adults with mild to moderate asthma or COPD. Researchers will give different doses to see how the body handles the drug and monitor for any problems.
Phase: PHASE1 • Sponsor: Generate Biomedicines • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
First human test for new eczema treatment begins
Knowledge-focused OngoingThis is the very first study in humans for a new potential eczema (atopic dermatitis) treatment called GB-7624. It will test the safety and side effects of single and multiple doses in 40 healthy adult volunteers. The main goal is to see how the body handles the drug and what dos…
Phase: PHASE1 • Sponsor: Generate Biomedicines • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:56 UTC